Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zealand Pharma
Biotech
Boehringer shares more ph. 2 obesity data for Lilly, Novo rival
Boehringer is sharing more on its Zealand Pharma-partnered obesity prospect, with new data showing nearly 19% weight loss in a phase 2 trial.
Gabrielle Masson
Jun 23, 2023 5:15pm
Boehringer posts slim slice of obesity data on Lilly, Novo rival
May 10, 2023 5:20am
Zealand rival to Takeda bowel disease drug hits goal in phase 3
Sep 30, 2022 9:00am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
Moderna CFO Gomez departs after just one day—Chutes & Ladders
May 13, 2022 9:30am
Rezolute bags $130M to take rare disease drug into pivotal trial
May 2, 2022 8:17am